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Clinico-pathology, hematology and biochemistry responses in buffaloes towards 
Pasteurella multocida type B: 2 immunogen lypopolysaccharide via oral and 
intravenous routes of infection 
 
ABSTRACT 
Haemorrhagic septicaemia is a disease caused by Pasteurella multocida serotype B: 2 and E: 
2. The organism causes acute, highly fatal septicaemic disease with high morbidity and 
mortality in cattle and more susceptible in buffaloes. Lipopolysaccharide can be found on the 
outer cell wall of the organism. Lipopolysaccharide is released during multiplication which 
leads to inflammatory reaction. It represents the endotoxin of P. multocida type B: 2 and 
responsible for toxicity in haemorrhagic septicaemia which plays an important role in the 
pathogenesis of the disease. Therefore, the aim of this study was to investigate the clinical 
signs, blood parameters, gross post mortem lesions and histopathology changes caused by P. 
multocida type B:2 immunogen lipopolysaccharide infections initiated through intravenous 
and oral routes of infection. 9 buffalo heifers were divided equally into 3 treatment groups. 
Group 1 was inoculated orally with 10 ml of phosphate buffer saline (PBS); Group 2 and 3 
were inoculated with 10 ml of lipopolysaccharide broth intravenously and orally respectively. 
For the clinical signs, there were significant differences (p < 0.05) in temperature between the 
control, intravenous and oral group. In hematology and biochemistry findings, there were 
significant differences (p < 0.05) in erythrocytes, haemoglobin, PCV, MCV, lymphocytes, 
monocytes, eosinophils, GGT and albumin between the control, intravenous and oral group. 
However, there were no significant differences (p > 0.05) in the MCHC, leukocytes, band 
neutrophils, basophils, thrombocytes, plasma protein, icterus index, total protein, globulin 
and A:G ratio between intravenous and oral group. For Group 2 buffaloes, there were gross 
lesions in the lung, trachea, heart, liver, spleen, and kidney. In contrast, lesions were only 
observed in the lung, trachea and liver of Group 3 buffaloes. There were significant 
differences (p < 0.05) in hemorrhage and congestion; necrosis and degeneration; and 
inflammatory cells infiltration between experimental groups and control group. However, 
there were no significant differences (p > 0.05) in edema lesion between groups. In 
conclusion, this study is a proof that oral route infection of P. multocida type B:2 immunogen 
lipopolysaccharide can be used to stimulate host cell responses where oral vaccine through 
feed could be developed in the near future. 
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